HbA1c

Ask MedXY AI

type 2 diabetes clinical trial heart failure immunotherapy obesity cardiovascular risk atrial fibrillation critical care biomarkers artificial intelligence type 1 diabetes clinical trials Hypertension oncology Cardiology Mortality public health cardiovascular disease diabetes Alzheimer's disease breast cancer epidemiology

Latest news

Tag

Clinical Updatesautomated insulin deliveryHbA1c

Transitioning to Tubeless Automated Insulin Delivery: Clinical Insights from the RADIANT Trial and Contemporary Management of Type 1 Diabetes

By MedXY|Mar 9, 2026

This review synthesizes the landmark RADIANT trial findings, demonstrating the efficacy of transitioning patients from multiple daily injections to tubeless automated insulin delivery, while integrating broader evidence on genetic susceptib

DentistryDiabetes MellitusHbA1c

Beyond the Oral Cavity: Probiotic Adjuncts in Periodontitis Yield Systemic Glycemic Benefits for Diabetic Patients

By MedXY|Jan 10, 2026

A randomized clinical trial reveals that while Limosilactobacillus reuteri probiotics do not enhance local periodontal healing compared to standard therapy, they significantly improve systemic glycemic control (HbA1c) in patients with diabe

AnesthesiologyDiabetes MellitusHbA1c

European Perioperative Diabetes Care: Significant Practice Variation Impacts 30-Day Recovery Outcomes

By MedXY|Dec 19, 2025

The MOPED study of over 6,000 European patients reveals significant international variations in perioperative diabetes management. Findings demonstrate that higher preoperative HbA1c levels and practice inconsistencies are linked to fewer d

Diabetes & Endocrinologyclinical trialdiabetes

Voucher for Healthy Foods and Diabetes Control: A Randomized Clinical Trial

By MedXY|Dec 13, 2025

This clinical trial evaluated monthly grocery vouchers for improving diabetes control in food-insecure patients, finding increased self-reported fruit and vegetable intake but no significant HbA1c improvement.

Diabetes & EndocrinologyHbA1chypoglycemia

Impact of Multifactorial Interventions on Retinopathy in Type 2 Diabetes: Insights from the J-DOIT3 Trial

By MedXY|Oct 24, 2025

This analysis highlights how intensive multifactorial management and glycemic control influence diabetic retinopathy onset, emphasizing the risks associated with hypoglycemia despite good glycemic control.

2 / 2

Ask MedXY AI

Most popular

Intimate Health

Five Benefits for Women Continuing Sexual Activity After Menopause

Intimate Health

Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

Nursing & care

How often should a couple have sex?

Cardiology

Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

General Surgery

Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models